(Q51613767)

English

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.

scientific article published in November 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

1 reference

based on heuristic

inferred from title

Stefano Del Prato

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

author name string

S Vigili de Kreutzenberg

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

A Riccio

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

L Maifreni

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

E Duner

5

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

G Lisato

6

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

M Iavicoli

7

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

A Tiengo

8

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

publication date

1 November 1990

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

33

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

11

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

688-695

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

https://scigraph.springernature.com/pub.10.1007/bf00400571

0 references

Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzymatic microdetermination of serum free fatty acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fatty acids on glucose production and utilization in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor depletion in diabetes mellitus: correction with therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-Mediated Glucose Disposal in Type I Diabetes: Evidence for Insulin Resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable effects of supplemental orinase in insulin-treated labile diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal Glucose Regulation of Insulin Secretion in Models of Reduced B-Cell Mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New tactics for type 2 diabetes: regimens based on intermediate-acting insulin taken at bedtime.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of plasma insulin levels following administration of tolbutamide and glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic Usefulness

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of short-term insulin therapy upon therapeutic response to glipizide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined glyburide and insulin therapy in type II diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overnight basal insulin requirements in fasting insulin-dependent diabetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological basis of the effectiveness of combined insulin-tolbutamide therapy in stable diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic islet glucose metabolism and regulation of insulin secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/2127573

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00400571

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2127573

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51613767&oldid=1380711626"